Short-term efficacy of intravitreal conbercept in treatment-naive patients with polypoidal choroidal vasculopathy.

about

Short-term efficacy of intravitreal conbercept in treatment-naive patients with polypoidal choroidal vasculopathy.

Item

http://www.wikidata.org/entity/Q54938810

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Short-term efficacy of intravi ...... poidal choroidal vasculopathy.

@en

Short-term efficacy of intravi ...... poidal choroidal vasculopathy.

@nl

type

Item

label

Short-term efficacy of intravi ...... poidal choroidal vasculopathy.

@en

Short-term efficacy of intravi ...... poidal choroidal vasculopathy.

@nl

prefLabel

Short-term efficacy of intravi ...... poidal choroidal vasculopathy.

@en

Short-term efficacy of intravi ...... poidal choroidal vasculopathy.

@nl

P1476

Short-term efficacy of intravi ...... ypoidal choroidal vasculopathy

@en

P2093

Bing Liu

http://www.w3.org/2001/XMLSchema#string

Chengguo Zuo

http://www.w3.org/2001/XMLSchema#string

Feng Wen

http://www.w3.org/2001/XMLSchema#string

Lan Mi

http://www.w3.org/2001/XMLSchema#string

Miaoling Li

http://www.w3.org/2001/XMLSchema#string

Xiongze Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Polypoidal choroidal vasculopathy in Taiwanese patients.

Polypoidal choroidal vasculopathy.

Recombinant anti-vascular endothelial growth factor fusion protein efficiently suppresses choridal neovasularization in monkeys

Improvement of angiographic findings of polypoidal choroidal vasculopathy after intravitreal injection of ranibizumab monthly for 3 months.

Efficacy and safety of conbercept as a primary treatment for choroidal neovascularization secondary to punctate inner choroidopathy.

Novel VEGF decoy receptor fusion protein conbercept targeting multiple VEGF isoforms provide remarkable anti-angiogenesis effect in vivo.

1-year results of combined half-dose photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathy

Short-term effectiveness of intravitreal bevacizumab vs. ranibizumab injections for patients with polypoidal choroidal vasculopathy

Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration.

P304

339-345

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DDDT.S158368

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yuting Peng

P577

2018-02-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29497280

http://www.w3.org/2001/XMLSchema#string

P932

5823069

http://www.w3.org/2001/XMLSchema#string